1. Home
  2. Category
  3. Professional Issues

Safe Handling

Quality & Safety

5-Fluorouracil Infiltrations and Ambulatory Pumps: Education, Prevention, and Management Considerations

Chelsea Bostelman
CJON 2019, 23(5), 537-539 DOI: 10.1188/19.CJON.537-539
Although uncommon, 5-fluorouracil (5-FU) infiltrations do occur. Two case studies involving 5-FU infiltration from totally implanted venous access devices identified at the conclusion of a 46-hour continuous infusion via an ambulatory infusion pump are presented. These cases highlight the...
0
No votes yet
Read this Article
Letter to the Editor

Response to “Personal Protective Equipment: Evaluating Usage Among Inpatient and Outpatient Oncology Nurses”

Seth Eisenberg
Denise Menonna-Quinn
CJON 2019, 23(5), 462 DOI: 10.1188/19.CJON.462
I read with great interest the recent article entitled “Personal Protective Equipment: Evaluating Usage Among Inpatient and Outpatient Oncology Nurses” by Menonna-Quinn, Polovich, and Marshall (2019). In addition to furthering the body of knowledge regarding personal protective equipment (PPE)...
0
No votes yet
Read this Article
Joint Position Statement From the Oncology Nursing Society and the Hematology/Oncology Pharmacy Association
Advanced Print Exclusive

Ensuring Healthcare Worker Safety When Handling Hazardous Drugs

ONF 2019, 1-2 DOI:
Hazardous drugs (HDs) are chemicals that demonstrate one or more of the following characteristics: carcinogenicity, genotoxicity, teratogenicity, reproductive toxicity, or organ toxicity. In addition, newer drugs with a structural or toxicity profile that mimics an agent known to be hazardous by...
0
No votes yet
Read this Article
Quality & Safety

USP <800>: Gaining Compliance Through Implementation of a Hazardous Drug Control Program

Kelley Blake
CJON 2019, 23(3), 324-326 DOI: 10.1188/19.CJON.324-326
Medical facilities in the United States are faced with the challenge of meeting the December 2019 requirements of U.S. Pharmacopeial Convention General Chapter <800> (USP <800>) Hazardous Drugs—Handling in Healthcare Settings. A 300-bed hospital in western Washington formed a practice...
0
No votes yet
Read this Article
CNE Article

Personal Protective Equipment: Evaluating Usage Among Inpatient and Outpatient Oncology Nurses

Denise Menonna-Quinn
Martha Polovich
Brenda Marshall
CJON 2019, 23(3), 260-265 DOI: 10.1188/19.CJON.260-265
Background: Chemotherapy agents have long been considered hazardous, and safety for healthcare providers when administering these drugs is a primary concern. Personal protective equipment (PPE) is known to decrease exposure to hazardous drugs. Studies report that PPE is underused among healthcare...
4
Average: 4 (2 votes)
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.